Comparison of two new angiogenesis PET tracers 68Ga-NODAGA-E[c(RGDyK)]2 and 64Cu-NODAGA-E[c(RGDyK)]2; in vivo imaging studies in human xenograft tumors

Nuclear Medicine and Biology

Volumn 41, Issue 3, 2014, Pages 259-267

  Oxboel, Jytte ^a   Brandt Larsen, Malene ^b   Schjoeth Eskesen, Christina ^b   Myschetzky, Rebecca ^a,b   El Ali, Henrik H ^a   Madsen, Jacob ^b   Kjaer, Andreas ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b University of Copenhagen   (Denmark)

Author keywords

64Cu; 68Ga; Angiogenesis; Cancer; Integrin v 3; Molecular imaging; NODAGA; RGD dimer

Indexed keywords

(64)CU; (68)GA; ANGIOGENESIS; CANCER; INTEGRIN Α(V)Β(3); MOLECULAR IMAGING; NODAGA; RGD DIMER;

ACETATES; ANIMALS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; COPPER RADIOISOTOPES; FEMALE; GALLIUM RADIOISOTOPES; GLIOBLASTOMA; HETEROCYCLIC COMPOUNDS, 1-RING; HUMANS; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; OLIGOPEPTIDES; POSITRON-EMISSION TOMOGRAPHY; RADIOCHEMISTRY; RADIOMETRY; TISSUE DISTRIBUTION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84893969986     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2013.12.003     Document Type: Article

References (30)

1. Guo W., Giancotti F.G. Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 2004, 5:816-826.
2. Liu Z., Wang F., Chen X. Integrin alpha(v)beta(3)-targeted cancer therapy. Drug Dev Res 2008, 69:329-339.
3. Millard M., Odde S., Neamati N. Integrin targeted therapeutics. Theranostics 2011, 1:154-188.
4. Dijkgraaf I., Beer A.J., Wester H.J. Application of RGD-containing peptides as imaging probes for alphavbeta3 expression 2 2907. Front Biosci 2009, 14:887-899.
5. Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 1996, 12:697-715.
6. Ruoslahti E., Pierschbacher M.D. New perspectives in cell adhesion: RGD and integrins. Science 1987, 238:491-497.
7. Buchegger F., Viertl D., Baechler S., Dunet V., Kosinski M., Poitry-Yamate C., et al. 68Ga-NODAGA-RGDyK for alphavbeta3 integrin PET imaging. Preclinical investigation and dosimetry. Nuklearmedizin 2011, 50:225-233.
8. Chen X., Liu S., Hou Y., Tohme M., Park R., Bading J.R., et al. MicroPET imaging of breast cancer alphav-integrin expression with 64Cu-labeled dimeric RGD peptides. Mol Imaging Biol 2004, 6:350-359.
9. Chen X., Tohme M., Park R., Hou Y., Bading J.R., Conti P.S. Micro-PET imaging of alphavbeta3-integrin expression with 18F-labeled dimeric RGD peptide. Mol Imaging 2004, 3:96-104.
10. Decristoforo C., Hernandez Gonzalez I., Carlsen J., Rupprich M., Huisman M., Virgolini I., et al. 68Ga- and 111In-labelled DOTA-RGD peptides for imaging of alphavbeta3 integrin expression. Eur J Nucl Med Mol Imaging 2008, 35:1507-1515.
11. Dijkgraaf I., Terry S.Y., McBride W.J., Goldenberg D.M., Laverman P., Franssen G.M., et al. Imaging integrin alpha-v-beta-3 expression in tumors with an 18F-labeled dimeric RGD peptide. Contrast Media Mol Imaging 2013, 8:238-245.
12. Dumont R.A., Deininger F., Haubner R., Maecke H.R., Weber W.A., Fani M. Novel (64)Cu- and (68)Ga-labeled RGD conjugates show improved PET imaging of alpha(nu)beta(3) integrin expression and facile radiosynthesis. J Nucl Med 2011, 52:1276-1284.
13. Ferl G.Z., Dumont R.A., Hildebrandt I.J., Armijo A., Haubner R., Reischl G., et al. Derivation of a compartmental model for quantifying 64Cu-DOTA-RGD kinetics in tumor-bearing mice. J Nucl Med 2009, 50:250-258.
14. Jeong J.M., Hong M.K., Chang Y.S., Lee Y.S., Kim Y.J., Cheon G.J., et al. Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice. J Nucl Med 2008, 49:830-836.
15. Knetsch P.A., Petrik M., Griessinger C.M., Rangger C., Fani M., Kesenheimer C., et al. [68Ga]NODAGA-RGD for imaging alphavbeta3 integrin expression. Eur J Nucl Med Mol Imaging 2011, 38:1303-1312.
16. Li Z.B., Cai W., Cao Q., Chen K., Wu Z., He L., et al. (64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression. J Nucl Med 2007, 48:1162-1171.
17. Li Z.B., Chen K., Chen X. (68)Ga-labeled multimeric RGD peptides for microPET imaging of integrin alpha(v)beta (3) expression. Eur J Nucl Med Mol Imaging 2008, 35:1100-1108.
18. Liu S. Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging. Mol Pharm 2006, 3:472-487.
19. Liu S. Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency. Bioconjug Chem 2009, 20:2199-2213.
20. Liu Z., Li Z.B., Cao Q., Liu S., Wang F., Chen X. Small-animal PET of tumors with (64)Cu-labeled RGD-bombesin heterodimer. J Nucl Med 2009, 50:1168-1177.
21. Oxboel J., Schjoeth-Eskesen C., El-Ali H.H., Madsen J., Kjaer A. (64)Cu-NODAGA-c(RGDyK) is a promising new angiogenesis PET tracer: correlation between tumor uptake and integrin alpha(V)beta(3) expression in human neuroendocrine tumor xenografts. Int J Mol Imaging 2012, 2012. [379807].
22. Pohle K., Notni J., Bussemer J., Kessler H., Schwaiger M., Beer A.J. 68Ga-NODAGA-RGD is a suitable substitute for (18)F-Galacto-RGD and can be produced with high specific activity in a cGMP/GRP compliant automated process. Nucl Med Biol 2012, 39:777-784.
23. Wu Y., Zhang X., Xiong Z., Cheng Z., Fisher D.R., Liu S., et al. microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide. J Nucl Med 2005, 46:1707-1718.
24. Thisgaard H., Jensen M., Elema D.R. Medium to large scale radioisotope production for targeted radiotherapy using a small PET cyclotron. Appl Radiat Isot 2011, 69:1-7.
25. Binderup T., El-Ali H.H., Ambrosini V., Skovgaard D., Jensen M.M., Li F., et al. Molecular imaging with small animal PET/CT. Curr Med Imaging Rev 2011, 7:234-247.
26. Stabin M.G., Sparks R.B., Crowe E. OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 2005, 46:1023-1027.
27. Cai H.C., Conti P.S. RGD-based PET tracers for imaging receptor integrin αvβ3 expression. J Label Compd Radiopharm 2013, 10.1002/jlcr.2999.
28. Haubner R., Beer A.J., Wang H., Chen X. Positron emission tomography tracers for imaging angiogenesis. Eur J Nucl Med Mol Imaging 2010, 10.1007/s00259-010-1503-4.
29. Beer A.J., Kessler H., Wester H.J., Schwaiger M. PET imaging of integrin alphaVbeta3 expression. Theranostics 2011, 1:48-57.
30. Velikyan I., Beyer G.J., Bergstrom-Pettermann E., Johansen P., Bergstrom M., Langstrom B. The importance of high specific radioactivity in the performance of 68Ga-labeled peptide. Nucl Med Biol 2008, 35:529-536.